Evidence map›Paper›PMID 37978895›Full record

ReviewInflammatory bowel diseases2024

The Crohn's Disease Exclusion Diet: A Comprehensive Review of Evidence, Implementation Strategies, Practical Guidance, and Future Directions.

Rotem Sigall Boneh, Catherine Westoby, Ilan Oseran, Chen Sarbagili-Shabat, Lindsey G Albenberg, Paolo Lionetti, Víctor Manuel Navas-López, Javier Martín-de-Carpi, Henit Yanai, Nitsan Maharshak and 2 more

Registry-linked trialOpen access · hybridAbstract readReview
In one paragraph

Review in Inflammatory bowel diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07334340 (Modified vs Standard Crohn´s Disease Exclusion Diet), which is not on this map. Cited by 46 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 1 pooled it
17.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07334340 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Modified vs Standard Crohn´s Disease Exclusion Diet: Evaluation of a Nordic Adaptation of Nutritional Therapy in Paediatric Crohn's Diseas

TypeinterventionalSponsorVastra Gotaland RegionRan2026 to 2030Enrolled30ConditionsPediatric Crohns DiseaseArmsNordic Crohn´s Disease Exclusion Diet
3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 1 synthesis or guideline pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Single-center experience of the Crohn's disease exclusion diet in the United States: A retrospective study.Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition · 2026
    Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Inflammatory Bowel Disease in Children and Young People Living With Overweight or Obesity: A Critical Narrative Review.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2026
    Review
  17. Article
  18. Article
  19. A Developmental Perspective on the Intestinal Microbiota in Crohn's Disease.International journal of molecular sciences · 2026
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 10 institutions in 7 countries.

Rotem Sigall BonehPediatric Gastroenterology and Nutrition Unit, The E. Wolfson Medical Center, Holon, Israel.ORCID 0000-0002-5082-7634
Catherine WestobyDepartment of Nutrition and Dietetics, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
Ilan OseranDepartment of Psychology, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Chen Sarbagili-ShabatPediatric Gastroenterology and Nutrition Unit, The E. Wolfson Medical Center, Holon, Israel.
Lindsey G AlbenbergDivision of Gastroenterology, Hepatology, and Nutrition, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Paolo LionettiDepartment Neurofarba, University of Florence, Meyer children's Hospital IRCCS, Florence, Italy.ORCID 0000-0003-1056-4400
Víctor Manuel Navas-LópezPediatric Gastroenterology and Nutrition Unit. Hospital Regional Universitario de Málaga. IBIMA. Málaga, Spain.
Javier Martín-de-CarpiPaediatric Gastroenterology, Hepatology and Nutrition Department, Hospital Sant Joan de Déu, Barcelona, Spain.
Henit YanaiIBD center, Division of Gastroenterology, Rabin Medical center, Petach Tikva, Israel.ORCID 0000-0001-5483-5271
Nitsan MaharshakTel Aviv Medical Center, affiliated to the Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Johan Van LimbergenDepartment of Paediatric Gastroenterology and Nutrition, Amsterdam University Medical Centers, Emma Children's Hospital, Amsterdam, the Netherlands.
Eytan WineDivision of Pediatric Gastroenterology, Department of Pediatrics, University of Alberta, Edmonton, AB, Canada.ORCID 0000-0002-3458-4142
Tel Aviv University · ILBen-Gurion University of the Negev · ILChildren's Hospital of Philadelphia · USEmma Kinderziekenhuis · NLHospital Regional Universitario de Málaga · ESHospital Sant Joan de Déu Barcelona · ESMeyer Children's Hospital · ILUniversity Hospital Southampton NHS Foundation Trust · GBUniversity of Alberta · CAWolfson Medical Center · IL

Funding

Nestle Health Sciences
6 · The paper itself

Abstract

Dietary therapy is increasingly recognized for the management of Crohn's disease (CD) over recent years, including the use of exclusive enteral nutrition (EEN) as first-line therapy for pediatric CD according to current guidelines. The Crohn's disease exclusion diet (CDED) is a whole-food diet designed to reduce exposure to dietary components that are potentially pro-inflammatory, mediated by negative effects on the gut microbiota, immune response, and the intestinal barrier. The CDED has emerged as a valid alternative to EEN with cumulative evidence, including randomized controlled trials, supporting use for induction of remission and possibly maintenance in children and adults. We gathered a group of multidisciplinary experts, including pediatric and adult gastroenterologists, inflammatory bowel diseases (IBD) expert dietitians, and a psychologist to discuss the evidence, identify gaps, and provide insights into improving the use of CDED based on a comprehensive review of CDED literature and professional experience. This article reviews the management of CDED in both children and adults, long-term aspects of CDED, indications and contraindications, selecting the best candidates, identifying challenges with CDED, globalization, the role of the multidisciplinary team, especially of dietitian, and future directions. We concluded that CDED is an established dietary therapy that could serve as an alternative to EEN in many pediatric and adult cases, especially with mild to moderate disease. In severe disease, complicated phenotypes, or with extraintestinal involvement, CDED should be considered on a case-by-case basis, according to physician and dietitians' discretion. More studies are warranted to assess the efficacy of CDED in different scenarios.

Indexed as

Crohn DiseaseAdultChildEnteral NutritionHumansPractice Guidelines as TopicCrohn’s diseaseexclusion dietsgut microbiomenutritional therapy

Identifiers

PMID37978895
PMCPMC11446999
OpenAlexW4388801299

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.